Stocks
GoodRx Holdings Financial Statements (GDRX) |
||||||||||
| GoodRx Holdingssmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 10.05.2023 | 09.08.2023 | 09.11.2023 | 29.02.2024 | 09.05.2024 | 09.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 184.0 | 189.7 | 180.0 | 196.6 | 197.9 | 764.2 | |||
| Operating Income, bln rub | 16.7 | 18.3 | -38.3 | -15.5 | 20.4 | -15.0 | ||||
| EBITDA, bln rub | ? | 31.7 | 42.2 | 1.14 | 29.2 | 36.4 | 109.0 | |||
| Net profit, bln rub | ? | -3.29 | 58.8 | -38.5 | -25.9 | -1.01 | -6.59 | |||
| OCF, bln rub | ? | 32.3 | 29.9 | 60.3 | 15.9 | 42.6 | 148.6 | |||
| CAPEX, bln rub | ? | 14.3 | 15.0 | 13.6 | 12.9 | 20.6 | 62.1 | |||
| FCF, bln rub | ? | 18.0 | 14.9 | 46.6 | 3.00 | 22.0 | 86.5 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 156.0 | 155.0 | 199.6 | 154.6 | 149.0 | 658.2 | ||||
| Cost of production, bln rub | 16.7 | 16.3 | 18.7 | 57.5 | 28.4 | 121.0 | ||||
| R&D, bln rub | 32.9 | 31.3 | 39.6 | 31.5 | 31.0 | 133.4 | ||||
| Interest expenses, bln rub | 13.1 | 14.1 | 14.7 | 14.8 | 14.6 | 58.2 | ||||
| Assets, bln rub | 1 612 | 1 692 | 1 708 | 1 589 | 1 454 | 1 454 | ||||
| Net Assets, bln rub | ? | 827.5 | 895.4 | 881.3 | 762.0 | 631.1 | 631.1 | |||
| Debt, bln rub | 715.9 | 714.4 | 711.5 | 711.1 | 710.2 | 710.2 | ||||
| Cash, bln rub | 761.1 | 762.0 | 794.9 | 672.3 | 533.3 | 533.3 | ||||
| Net debt, bln rub | -45.2 | -47.6 | -83.4 | 38.8 | 176.9 | 176.9 | ||||
| Ordinary share price, rub | 6.25 | 5.52 | 5.63 | 6.70 | 7.10 | 5.29 | ||||
| Number of ordinary shares, mln | 412.4 | 412.2 | 413.4 | 403.2 | 390.0 | 390.0 | ||||
| Market cap, bln rub | 2 578 | 2 275 | 2 328 | 2 702 | 2 769 | 2 063 | ||||
| EV, bln rub | ? | 2 533 | 2 228 | 2 244 | 2 741 | 2 946 | 2 240 | |||
| Book value, bln rub | 218 | 281 | 288 | 195 | 58 | 58 | ||||
| EPS, rub | ? | -0.01 | 0.14 | -0.09 | -0.06 | 0.00 | -0.02 | |||
| FCF/share, rub | 0.04 | 0.04 | 0.11 | 0.01 | 0.06 | 0.22 | ||||
| BV/share, rub | 0.53 | 0.68 | 0.70 | 0.48 | 0.15 | 0.15 | ||||
| EBITDA margin, % | ? | 17.2% | 22.3% | 0.64% | 14.9% | 18.4% | 14.3% | |||
| Net margin, % | ? | -1.79% | 31.0% | -21.4% | -13.2% | -0.51% | -0.86% | |||
| FCF yield, % | ? | 3.56% | 3.05% | 4.13% | 3.05% | 3.12% | 4.19% | |||
| ROE, % | ? | -5.85% | 1.32% | 1.71% | -1.16% | -1.04% | -1.04% | |||
| ROA, % | ? | -3.00% | 0.70% | 0.88% | -0.56% | -0.45% | -0.45% | |||
| P/E | ? | -53.2 | 193.0 | 154.9 | -304.7 | -420.4 | -313.2 | |||
| P/FCF | 28.1 | 32.8 | 24.2 | 32.7 | 32.0 | 23.9 | ||||
| P/S | ? | 3.45 | 3.05 | 3.16 | 3.60 | 3.62 | 2.70 | |||
| P/BV | ? | 11.8 | 8.09 | 8.09 | 13.9 | 47.6 | 35.5 | |||
| EV/EBITDA | ? | 38.6 | 22.8 | 23.0 | 26.3 | 27.0 | 20.6 | |||
| Debt/EBITDA | -0.69 | -0.49 | -0.85 | 0.37 | 1.62 | 1.62 | ||||
| R&D/CAPEX, % | 230.3% | 209.1% | 290.3% | 245.0% | 150.5% | 214.9% | ||||
| CAPEX/Revenue, % | 7.77% | 7.89% | 7.58% | 6.55% | 10.4% | 8.13% | ||||
| GoodRx Holdings shareholders | ||||||||||
